I agree that this site is using cookies. You can find further informations here.
X
Peer, Cody J
139  results:
OpenAccess-fulltext X
Search for persons X
?
1

First-in-human phase 1 clinical trial of anti-core 1 O-glyc..:

Cole, Christopher B ; Morelli, Maria Pia ; Fantini, Massimo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053355/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

A Phase II Trial of Guadecitabine in Children and Adults wi..:

Ligon, John A ; Sundby, R. Taylor ; Wedekind, Mary F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851965/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

The combination of trametinib and ganitumab is effective in..:

Hebron, Katie E ; Wan, Xiaolin ; Roth, Jacob S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852065/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Cardiac toxicity in a pilot study of duvelisib and ibrutini..:

Paul, Shira R ; Rosing, Douglas R ; Haigney, Mark C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681272/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

TRLS-02. FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMAC..:

Jackson, Sadhana ; Glod, John ; Peer, Cody...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260119/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Correction: First-in-human phase 1 clinical trial of anti-c..:

Cole, Christopher B ; Morelli, Maria Pia ; Fantini, Massimo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131449/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Pharmacokinetics and tolerability of the dual TORC1/2 inhib..:

Wei, Bih-Rong ; Peer, Cody J ; Richardson, William J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794608/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Biological Effects of Modifications of the Englerin A Glyco..:

Seenadera, Sarath P. D ; Long, Sarah A ; Akee, Rhone...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465829/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

A Single-arm Phase II Study Combining NLG207, a Nanoparticl..:

Schmidt, Keith T ; Karzai, Fatima ; Bilusic, Marijo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438911/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

DIPG-10. A Phase I trial of panobinostat following radiatio..:

Monje, Michelle ; Cooney, Tabitha ; Glod, John...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164905/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Pharmacokinetic Simulation Analysis of Less Frequent Nivolu..:

Peer, Cody J ; Heiss, Brian L ; Goldstein, Daniel A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749861/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Systemic immune changes accompany combination treatment wit..:

Pegna, Guillaume Joe ; Lee, Min‐Jung ; Peer, Cody J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972172/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Low serum mesothelin in pancreatic cancer patients results ..:

Zhang, Xianyu ; Yu, Yunkai ; Peer, Cody J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079715/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

DDEL-04. Pharmacokinetic/Pharmacodynamic analysis of the DN..:

Groves, Andrew ; Jones, Kristen ; Cameron, Amy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164756/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Quantitation of the Next-Generation Imipridone ONC206 in Hu..:

Goodell, Jennifer C ; Zimmerman, Sara M ; Peer, Cody J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983588/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15